Globus Medical unveils SCRIPT™ implants and XLIF™ Prone solution at NASS 2026 to enhance spine surgery.

Globus Medical introduced its SCRIPT™ patient-specific spinal implant platform and the XLIF™ Prone Procedural Solution at the 41st Annual North American Spine Society Meeting. These innovations aim to improve surgical planning and execution by integrating patient-specific implant design with connected surgical workflows. SCRIPT™ allows surgeons to customize implants and surgical plans, which can be integrated with navigation systems for precision. The XLIF™ Prone solution enhances patient positioning and surgical access for prone lateral spine procedures, reflecting Globus Medical's commitment to advancing integrated spine care technologies.

Globus Medical's stock trades at USD 76.40 on Pluang as of Oct 14, 2026 19:11 WIB, showing a modest 0.10% increase in one day. The company's market capitalization stands at $10.25 billion, reflecting its significant presence in the health sector. Trading volume reached 1,108,124 shares, indicating active investor interest around the time of the NASS 2026 event.